Cite
MLA Citation
D. Planchard et al.. “3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy.” European journal of cancer, vol. 51, n.d., pp. S624–. http://access.bl.uk/ark:/81055/vdc_100030628321.0x00001f